Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Selective detection and staining of toxic amyloid plaques, a potential biomarker present in the Alzheimer’s disease (AD) brain is crucial for both clinical diagnosis and monitoring AD disease progression. Herein, we report a coumarin-quinoline (CQ) conjugate-based turn-on near-infrared (NIR) fluorescence probe for specific detection of β-amyloid (Aβ) aggregates. CQ probe is highly sensitive and exhibits ~100-fold fluorescence enhancement in vitro upon binding Aβ aggregates with enhanced quantum yield. Furthermore, the probe has ~10-fold higher binding affinity towards Aβ aggregates (86 nM) compared to commonly used Thioflavin T. Most importantly, CQ probe displays unambiguous selectivity towards Aβ aggregates compared to other toxic protein aggregates such as tau, α-synuclein (α-Syn) and islet amyloid polypeptide (IAPP). In addition, CQ is nontoxic to neuronal cells and shows significant blood brain barrier permeability. Remarkably, CQ stains Aβ plaques in human brain tissue over co-existing tau aggregates and neurofibrillary tangles (NFTs), which are associated in AD and tauopathies. This is a highly desirable attribute to distinguish AD from tau pathology and mixed dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“AD is the most common and dominant form of dementia, which affects millions of people worldwide (Prince et al., 2013).”
BackgroundThe amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382 · cited 1×
“…accretion of Aβ, α-Syn, tau, IAPP, polyglutamine and superoxide dismutase are considered as causative factors for Alzheimer’s, tauopathies, diabetes Huntington’s, Parkinson’s and amyotrophic lateral sclerosis diseases, respectively (Knowles et al., 2014; Soto et al., 2003; Rajasekhar et al., 2015).”
BackgroundTau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Preparing Synthetic Aβ in Different Aggregation States
Stine, W. B., Jungbauer, L., Yu, C., & LaDu, M. J. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-744-0_2 · Cited by 403 · cited 1×
“The obtained sample was centrifuged, and the supernatant with oligomers was used for further experiments (Walsh et al., 1997; Stine et al., 2011; Rajasekhar et al., 2016a, 2016b).”
MethodTau Aggregation and Its Interplay with Amyloid-β
Nisbet, R. M., Polanco, J.-C., Ittner, L. M., & Götz, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1371-2 · Cited by 359 · cited 1×
“Misfolded Aβ peptide (predominantly Aβ42) and hyperphosphorylated tau protein undergo aggregation to form insoluble Aβ plaques and NFTs, respectively in the brain, which are the hallmarks of AD (Hamley et al., 2012; Nisbet et al., 2015; Iqbal et al., 2014).”
BackgroundPET/SPECT imaging agents for neurodegenerative diseases
Zhu, L., Ploessl, K., & Kung, H. F. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60430f · Cited by 185 · cited 1×
“While PET imaging is an important tool to image protein aggregates, it is expensive and hazardous to human health due to the use of radio-labeled nuclei (Zhu et al., 2014).”
BackgroundAβ peptide immunization restores blood‐brain barrier integrity in Alzheimer disease
Dickstein, D. L., Biron, K. E., Ujiie, M., Pfeifer, C. G., Jeffries, A. R., & Jefferies, W. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-3956com · Cited by 111 · cited 1×
“The brain lysate showed presence of CQ probe, which underscored the BBB crossing ability of CQ (Dickstein et al., 2006).”
Background
Cited by
Interrogating Amyloid Aggregates using Fluorescent Probes
Aliyan, A., Cook, N. P., & Martí, A. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00404 · Cited by 290
Rajasekhar, K., & Govindaraju, T. (2018) · RSC Advances · doi:10.1039/c8ra03620a · Cited by 150
Self-citationMoorthy, H., & Govindaraju, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01319 · Cited by 64
Self-citationUnambiguous Detection of Elevated Levels of Hypochlorous Acid in Double Transgenic AD Mouse Brain
Samanta, S., & Govindaraju, T. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00554 · Cited by 57
Self-citationLin, X., Liu, W., Dong, X., & Sun, Y. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.063 · Cited by 44
Metadata
- Authors
- Rajasekhar, K., Narayanaswamy, N., Murugan, N. A., Viccaro, K., Lee, H.-G., Shah, K., & Govindaraju, T.
- Venue
- Biosensors and Bioelectronics
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 98
- Pages
- 54-61
- ISSN
- 0956-5663 (ISSN-L)
- OpenAlex
- W2713453502
- Cited by
- 97
- References
- 12
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.